| Literature DB >> 1744716 |
C M O'Driscoll1, F Baker, M J Casey, G J Duffy.
Abstract
This case report demonstrates the successful localization of metastatic medullary thyroid carcinoma with 99mTc-labeled methoxyisobutylnitrile (MIBI). Disease recurrence was initially localized using 201Tl and by immunoscintigraphy with 111In-labeled anti-carcinoembryonic antigen (anti-CEA) antibody fragments. Scintigraphy with 99mTc-MIBI yielded higher target-to-background ratios than 201Tl or 111In-anti-CEA. Technetium-99m-MIBI may be a useful agent in the localization of recurrent medullary thyroid carcinoma.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1744716
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057